MedTrace Logo

Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI)

NCT07067437 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2025-07-16

No results posted yet for this study

Summary

To investigate clinical outcomes, late side effects, and cosmetic results of a single-fraction very accelerated partial breast irradiation as postoperative local treatment for the treatment of early stage breast cancer.

Conditions

  • Breast Neoplasms

Interventions

RADIATION

single-fraction very accelerated partial breast irradiation

Adjuvant accelerated partial breast brachytherapy, with interstitial multicatheter technique, in one fraction.

Sponsors & Collaborators

  • National Institute of Oncology, Hungary

    lead OTHER

Principal Investigators

  • Viktor Smanykó, MD · National Institute of Oncology, Budapest, Hungary

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2027-07-01
Completion
2032-08-01

Countries

  • France
  • Germany
  • Hungary
  • Lithuania
  • Poland
  • Portugal
  • Serbia
  • Spain
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07067437 on ClinicalTrials.gov